These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11281198)

  • 41. Introduction of the Thirty-Third Lauriston S. Taylor lecture in radiation protection and measurements, John D. Boice Jr.
    Brent RL
    Health Phys; 2011 Jan; 100(1):55-8. PubMed ID: 21399413
    [No Abstract]   [Full Text] [Related]  

  • 42. Lauriston S. Taylor lecture on radiation protection and measurements.
    Boice JD
    Health Phys; 2014 Feb; 106(2):145. PubMed ID: 24378486
    [No Abstract]   [Full Text] [Related]  

  • 43. Dosimetry of pediatric nuclear medicine procedures.
    Stabin MG; Gelfand MJ
    Q J Nucl Med; 1998 Jun; 42(2):93-112. PubMed ID: 9695662
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Implementation of a national metrology network of radionuclides used in nuclear medicine.
    dos Santos JA; Iwahara A; Nícoli IG; Corrêa RS; Alabarse FG; dos Santos CE; Xavier AM; Garcia EJ; Tauhata L; Lopes RT
    Appl Radiat Isot; 2006; 64(10-11):1114-8. PubMed ID: 16549360
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radiopharmaceuticals and their use in the current practice of nuclear medicine.
    Fejka RM
    Lippincotts Prim Care Pract; 1999; 3(6):531-45. PubMed ID: 10889704
    [No Abstract]   [Full Text] [Related]  

  • 46. OCULAR ORGAN DOSE ASSESSMENT OF NUCLEAR MEDICINE WORKERS HANDLING DIAGNOSTIC RADIONUCLIDES.
    Cho YI; Kim JM; Kim JH
    Radiat Prot Dosimetry; 2017 Jun; 175(2):209-216. PubMed ID: 27765833
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Application of NCRP air screening factors for evaluating both routine and episodic radionuclide releases to the atmosphere.
    Mohler HJ; Meyer KR; Grogan HA; Aanenson JW; Till JE
    Health Phys; 2004 Feb; 86(2):135-44. PubMed ID: 14744046
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Nuclear medicine. Now a specialty in itself].
    Granerus G; Hietala SO; Jacobsson H; Larsson SA; Måre K; Nilsson S; Wollmer P
    Lakartidningen; 1997 May; 94(21):2001-7. PubMed ID: 9198692
    [No Abstract]   [Full Text] [Related]  

  • 49. NCRP Vision for the Future and Program Area Committee Activities in 2017.
    Boice JD
    Health Phys; 2018 Feb; 114(2):232-242. PubMed ID: 30086021
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Summary of NCRP 2019 Annual Meeting, NCRP Meeting the Challenge at 90: Providing Best Answers to Your Most Pressing Questions About Radiation.
    Vetter RJ; Bushberg JT; Mettler FA
    Health Phys; 2020 Apr; 118(4):335-348. PubMed ID: 32118678
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radiation dose estimates in Indian adults in normal and pathological conditions due to 99Tcm-labelled radiopharmaceuticals.
    Tyagi K; Jain SC; Jain PC
    Radiat Prot Dosimetry; 2001; 95(1):37-42. PubMed ID: 11468803
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Future role of the NCRP in radiation health protection.
    Tenforde TS
    Health Phys; 2004 Sep; 87(3):312-8; discussion 318-9. PubMed ID: 15303070
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Fetus radiation doses from nuclear medicine and radiology diagnostic procedures. Potential risks and radiation protection instructions].
    Markou P
    Hell J Nucl Med; 2007; 10(1):48-55. PubMed ID: 17450255
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The use of radioactive substances in medicine - history and development prospects].
    Sheremeta MS; Trukhin AA; Korchagina MO
    Probl Endokrinol (Mosk); 2021 Oct; 67(6):59-67. PubMed ID: 35018762
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lauriston S. Taylor Lecture: Yucca mountain radiation standards, dose/risk assessments, thinking outside the box, evaluations, and recommendations.
    Moeller DW
    Health Phys; 2009 Nov; 97(5):376-91. PubMed ID: 19820447
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Report of a nationwide survey on actual administered radioactivities of radiopharmaceuticals for diagnostic reference levels in Japan.
    Watanabe H; Ishii K; Hosono M; Imabayashi E; Abe K; Inubushi M; Ohno K; Magata Y; Ono K; Kikuchi K; Wagatsuma K; Takase T; Saito K; Takahashi Y
    Ann Nucl Med; 2016 Jul; 30(6):435-44. PubMed ID: 27154308
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Use of radiopharmaceuticals, radiation burden and radiation risks in examination procedures in nuclear medicine].
    Husák V; Petrová K; Masopust J; Myslivecek M
    Cas Lek Cesk; 1999 May; 138(11):323-8. PubMed ID: 10422342
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nuclear Medicine Procedures in Children: Special Considerations.
    Gelfand MJ; Clements C; MacLean JR
    Semin Nucl Med; 2017 Mar; 47(2):110-117. PubMed ID: 28236999
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Welcome to the 38th Lauriston S. Taylor lecture on radiation protection and measurements.
    Boice JD
    Health Phys; 2015 Feb; 108(2):97-8. PubMed ID: 25551486
    [No Abstract]   [Full Text] [Related]  

  • 60. SNMMI Clinical Trials Network Research Series for Technologists: Introduction.
    Frye S; Butterfield R; Hoffman JM
    J Nucl Med Technol; 2021 Dec; 49(4):297-302. PubMed ID: 34862261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.